Loading company details...
Latest Form 4 (Nov 12, 2026): Brian J. Caveney (EVP, Pres of BLS, CMO & CSO): Sale of 2,000 shares, $744.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 12, 2026 | Brian J. Caveney, EVP, Pres of BLS, CMO & CSO | Sale | 2,000 | $744.1K |
| Nov 5, 2026 | Bryan T. Vaughn, EVP and President, Diagnostics | Sale | 306 | $108.2K |
| Nov 3, 2026 | Richelle P. Parham | Sale | 1,078 | $389.4K |
| Nov 3, 2026 | Akinbolade Oyegunwa, EVP, CIO & CTO | Exercise/Conversion | 370 | n/a |
| Nov 3, 2026 | Bryan T. Vaughn, EVP and President, Diagnostics | Exercise/Conversion | 500 | n/a |
| Sep 3, 2026 | Akinbolade Oyegunwa, EVP, CIO & CTO | Grant/Award | 750 | n/a |
| Sep 3, 2026 | Jonathan C. Meltzer, EVP, COO | Grant/Award | 900 | n/a |
| Sep 3, 2026 | Bryan T. Vaughn, EVP and President, Diagnostics | Grant/Award | 1,500 | n/a |
| Sep 3, 2026 | Brian J. Caveney, EVP, Pres of BLS, CMO & CSO | Grant/Award | 3,000 | n/a |
| Aug 18, 2026 | Kerrii B. Anderson | Sale | 3,000 | $954.1K |